Elanco Animal Health (ELAN) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Elanco Animal Health Reports Second Quarter 2024 Results
August 8, 2024 6:28 AM EDTRaises Full Year Revenue and Maintains Adjusted EBITDA Guidance Excluding Aqua Divestiture
Second Quarter 2024 Financial ResultsRevenue of $1,184 millionReported Net Loss of $50 million, Adjusted Net Income of $147 millionAdjusted EBITDA of $275 million, or 23.2% of RevenueReported EPS of $(0.10), Adjusted EPS of $0.30 Net leverage ratio of 5.6x Adjusted EBITDAYear over year growth rates are meaningfully... More